Epigenomics AG
Epigenomics AG is a molecular diagnostics company developing and manufacturing a pipeline of products for the diagnosis of cancer.
Epigenomics AG has raised €9.8M across 2 funding rounds, most recently a round in Oct 2014. Based in Berlin, Germany; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€9.8M
€9,770,000
Funding rounds
2
Investors
0
distinct backers
Active since
2013-08
latest 2014-10
Funding by year
EUR raised per yearEpigenomics AG — funding by year — interactive chart.
Data table
| Epigenomics AG — funding by year | |
|---|---|
| 2013 | €5.0M |
| 2014 | €4.8M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Exit likelihood5
base rate 11% (2+ rounds)
- ▼ Old (19y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-10-01 | Other | €4.8M | — | View deal → |
| 2013-08-01 | Other | €5.0M | — | View deal → |
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData